✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients

✍ Scribed by N. H. G. Holford; P. Clements; P. Collier; N. G. M. Orie; L. E. Bork; J. H. G. Jonkman

Publisher: Springer
Year: 1987
Tongue: English
Weight: 546 KB
Volume: 33
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00637555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quantification of metoprolol Beta2-adren

Quantification of metoprolol Beta2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling

✍ M.C.P. Braat; R.E. Jonkers; C.J. van Boxtel 📂 Article 📅 1992 🏛 Elsevier 🌐 English ⚖ 668 KB

An integrated pharmacokinetic-pharmacodynamic model was used to quantify the beta 2-blocking activity of metoprolol in seven asthmatic patients. The patients received a subcutaneous dose of terbutaline on two consecutive days. On day 1 they were pretreated with placebo and on day 2 with metoprolol 1

Pharmacokinetics and pharmacodynamics in

Pharmacokinetics and pharmacodynamics in critically ill patients

✍ Henry J. Mann; David W. Fuhs; Frank B. Cerra 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 951 KB

The pharmacokinetics and pharmacodynamic

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients

✍ T. W. B. Gehr; D. A. Sica; D. M. Grasela; K. L. Duchin 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 662 KB

The pharmacokinetics and pharmacodynamics of fosinoprilat, the diacid of fosinopril sodium (a new angiotensin-converting enzyme (ACE) inhibitor), were investigated in six haemodialysis patients. Intravenous 14C-fosinoprilat (7.5 mg), oral 14C-fosinopril sodium (10 mg) and oral fosinopril sodium (10

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients

✍ K. Tawara; K. Kawashima; H. Ishikawa; K. Yamamoto; K. Saito; A. Ebihara; S. Yosh 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 783 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitis

✍ U. Gladziwa; S. Wagner; K. V. Dakshinamurty; E.El Desoky; B. Dreuw; U. Klotz 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 393 KB

Fosinopril pharmacokinetics and pharmaco

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

✍ T. W. B. Gehr; D. A. Sica; D. M. Grasela; I. Fakhry; J. Davis; K. L. Duchin 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 595 KB

The pharmacokinetics and pharmacodynamics of fosinoprilat, the diacid of fosinopril sodium, a new angiotensin-converting enzyme (ACE) inhibitor, were investigated after the oral administration of 10 mg of fosinopril sodium to 6 chronic ambulatory peritoneal dialysis (CAPD) patients. The results from